US FDA

FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis

US FDA sent this email to their subscribers on March 29, 2023.

If your email program has trouble displaying this email, view as a webpage.

US Food and Drug Administration FDA

FDA Approves First Generic Cyclosporine Oral Solution for Cats for Treatment of Allergic Dermatitis

Today, the U.S. Food and Drug Administration approved Modulis for Cats, the first generic cyclosporine oral solution for cats. Modulis for Cats is indicated for the control of certain skin conditions resulting from a disease called feline allergic dermatitis.

Cats with feline allergic dermatitis may be intensely itchy and lick, chew and scratch at their skin and hair. As a result, affected cats can develop excoriations (due to the cat scratching itself), miliary dermatitis (a skin condition in cats that most commonly is due to allergic reaction), eosinophilic plaques (skin lesions), and self-induced alopecia (hair loss).

Read More Button Read More


You are subscribed to updates from FDA's Center for Veterinary Medicine.


This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo gOVDELlVERY

Text-only version of this email

If your email program has trouble displaying this email, view as a webpage. US Food and Drug Administration FDA FDA APPROVES FIRST GENERIC CYCLOSPORINE ORAL SOLUTION FOR CATS FOR TREATMENT OF ALLERGIC DERMATITIS Today, the U.S. Food and Drug Administration approved Modulis for Cats, the first generic cyclosporine oral solution for cats. Modulis for Cats is indicated for the control of certain skin conditions resulting from a disease called feline allergic dermatitis. Cats with feline allergic dermatitis may be intensely itchy and lick, chew and scratch at their skin and hair. As a result, affected cats can develop excoriations (due to the cat scratching itself), miliary dermatitis (a skin condition in cats that most commonly is due to allergic reaction), eosinophilic plaques (skin lesions), and self-induced alopecia (hair loss). Read More Button Read More You are subscribed to updates from FDA's Center for Veterinary Medicine. feedtwitterfacebookyoutubeflickr Manage Subscriptions  |   |  Help ---------------------------------------------------------------------------------------------------------------------------------- This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA GovDelivery logo gOVDELlVERY
Show all

The Latest Emails Sent By US FDA

More Emails, Deals & Coupons From US FDA

Email Offers, Discounts & Promos From Our Top Stores